Melinda C Power1, Eric J Tchetgen Tchetgen, David Sparrow, Joel Schwartz, Marc G Weisskopf. 1. From the aDepartment of Epidemiology, Harvard School of Public Health, Boston, MA; bDepartment of Environmental Health, Harvard School of Public Health, Boston, MA; cDepartment of Biostatistics, Harvard School of Public Health, Boston, MA; dVeterans Affairs Normative Aging Study, Boston, MA; and 5Department of Medicine, Boston University School of Medicine, Boston, MA.
Abstract
BACKGROUND: Studies of hypertension and cognition variously report adverse, null, and protective associations. We evaluated evidence supporting three potential explanations for this variation: an effect of hypertension duration, an effect of age at hypertension initiation, and selection bias due to dependent censoring. METHODS: The Normative Aging Study is a prospective cohort study of men in the greater Boston area. Participants completed study visits, including hypertension assessment, every 3-5 years starting in 1961. Seven hundred fifty-eight of 1,284 men eligible at baseline completed cognitive assessment between 1992 and 2005; we used the mean age-adjusted cognitive test Z score from their first assessment to quantify cognition. We estimated how becoming hypertensive and increasing age at onset and duration since hypertension initiation affect cognition. We used inverse probability of censoring weights to reduce and quantify selection bias. RESULTS: A history of hypertension diagnosis predicted lower cognition. Increasing duration since hypertension initiation predicted lower mean cognitive Z score (-0.02 standard units per year increase [95% confidence interval= -0.04 to -0.001]), independent of age at onset. Comparing participants with and without hypertension, we observed noteworthy differences in mean cognitive score only for those with a long duration since hypertension initiation, regardless of age at onset. Age at onset was not associated with cognition independent of duration. Analyses designed to quantify selection bias suggested upward bias. CONCLUSIONS: Previous findings of null or protective associations between hypertension and cognition likely reflect the study of persons with short duration since hypertension initiation. Selection bias may also contribute to cross-study heterogeneity.
BACKGROUND: Studies of hypertension and cognition variously report adverse, null, and protective associations. We evaluated evidence supporting three potential explanations for this variation: an effect of hypertension duration, an effect of age at hypertension initiation, and selection bias due to dependent censoring. METHODS: The Normative Aging Study is a prospective cohort study of men in the greater Boston area. Participants completed study visits, including hypertension assessment, every 3-5 years starting in 1961. Seven hundred fifty-eight of 1,284 men eligible at baseline completed cognitive assessment between 1992 and 2005; we used the mean age-adjusted cognitive test Z score from their first assessment to quantify cognition. We estimated how becoming hypertensive and increasing age at onset and duration since hypertension initiation affect cognition. We used inverse probability of censoring weights to reduce and quantify selection bias. RESULTS: A history of hypertension diagnosis predicted lower cognition. Increasing duration since hypertension initiation predicted lower mean cognitive Z score (-0.02 standard units per year increase [95% confidence interval= -0.04 to -0.001]), independent of age at onset. Comparing participants with and without hypertension, we observed noteworthy differences in mean cognitive score only for those with a long duration since hypertension initiation, regardless of age at onset. Age at onset was not associated with cognition independent of duration. Analyses designed to quantify selection bias suggested upward bias. CONCLUSIONS: Previous findings of null or protective associations between hypertension and cognition likely reflect the study of persons with short duration since hypertension initiation. Selection bias may also contribute to cross-study heterogeneity.
Authors: Sjoerd M Euser; Miranda T Schram; Albert Hofman; Rudi G J Westendorp; Monique M B Breteler Journal: Epidemiology Date: 2008-05 Impact factor: 4.822
Authors: Ge Li; Isaac C Rhew; Jane B Shofer; Walter A Kukull; John C S Breitner; Elaine Peskind; James D Bowen; Wayne McCormick; Linda Teri; Paul K Crane; Eric B Larson Journal: J Am Geriatr Soc Date: 2007-08 Impact factor: 5.562
Authors: Andreea M Rawlings; A Richey Sharrett; Andrea L C Schneider; Josef Coresh; Marilyn Albert; David Couper; Michael Griswold; Rebecca F Gottesman; Lynne E Wagenknecht; B Gwen Windham; Elizabeth Selvin Journal: Ann Intern Med Date: 2014-12-02 Impact factor: 25.391
Authors: Melinda C Power; Jennifer A Deal; A Richey Sharrett; Clifford R Jack; David Knopman; Thomas H Mosley; Rebecca F Gottesman Journal: Neurology Date: 2015-01-28 Impact factor: 9.910
Authors: Melinda C Power; Andreea Rawlings; A Richey Sharrett; Karen Bandeen-Roche; Josef Coresh; Christie M Ballantyne; Yashashwi Pokharel; Erin D Michos; Alan Penman; Alvaro Alonso; David Knopman; Thomas H Mosley; Rebecca F Gottesman Journal: Alzheimers Dement Date: 2017-09-12 Impact factor: 21.566
Authors: Keenan A Walker; A Richey Sharrett; Aozhou Wu; Andrea L C Schneider; Marilyn Albert; Pamela L Lutsey; Karen Bandeen-Roche; Josef Coresh; Alden L Gross; B Gwen Windham; David S Knopman; Melinda C Power; Andreea M Rawlings; Thomas H Mosley; Rebecca F Gottesman Journal: JAMA Date: 2019-08-13 Impact factor: 56.272
Authors: Rebecca F Gottesman; Andrea L C Schneider; Marilyn Albert; Alvaro Alonso; Karen Bandeen-Roche; Laura Coker; Josef Coresh; David Knopman; Melinda C Power; Andreea Rawlings; A Richey Sharrett; Lisa M Wruck; Thomas H Mosley Journal: JAMA Neurol Date: 2014-10 Impact factor: 18.302
Authors: Lindsay M Miller; Carmen A Peralta; Annette L Fitzpatrick; Chenkai Wu; Bruce M Psaty; Anne B Newman; Michelle C Odden Journal: J Hypertens Date: 2019-09 Impact factor: 4.844
Authors: Melinda C Power; Andrea L C Schneider; Lisa Wruck; Michael Griswold; Laura H Coker; Alvaro Alonso; Clifford R Jack; David Knopman; Thomas H Mosley; Rebecca F Gottesman Journal: Alzheimers Dement Date: 2016-04-29 Impact factor: 21.566
Authors: Andreea Monica Rawlings; Yingying Sang; Albert Richey Sharrett; Josef Coresh; Michael Griswold; Anna Maria Kucharska-Newton; Priya Palta; Lisa Miller Wruck; Alden Lawrence Gross; Jennifer Anne Deal; Melinda Carolyn Power; Karen Jean Bandeen-Roche Journal: Eur J Epidemiol Date: 2016-09-12 Impact factor: 8.082